Boston, MA 04/28/2014 (wallstreetpr) – Cerner Corporation (NASDAQ:CERN) expects the revenue in the second quarter of this financial year to be in the range of $790 to $830 million. New collaborations Claritas Genomics and Cerner Corp have decided to join forces to advance customized medicine by developing connectivity and tools that will integrate next generation sequence […]
